# Characterization of Treatment Responses in Lymphedema

> **NCT03783715** · — · TERMINATED · sponsor: **Stanford University** · enrollment: 2 (actual)

## Conditions studied

- Lymphedema

## Interventions

- **DRUG:** Ketoprofen

## Key facts

- **NCT ID:** NCT03783715
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-21
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Study was halted due to Covid-19 pandemic and unavailability of ketoprofen.
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03783715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03783715, "Characterization of Treatment Responses in Lymphedema". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03783715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*